A Phase 2, Open-Label Study of HTX 011 in a Multimodal Analgesic Regimen for Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2019
Price : $35 *
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Ibuprofen; Paracetamol
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 12 Mar 2019 Status changed from recruiting to completed.
- 10 Oct 2018 New trial record
- 03 Oct 2018 Status changed from not yet recruiting to recruiting.